Genzyme, BioMarin start Aldurazyme Phase III

GENZ and BMRN will begin next week an international Phase III trial of their Aldurazyme laronidase alpha-L-iduronidase enzyme replacement therapy to treat mucopolysaccharidosis-I (MPS-I). The partners...